𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of bucillamine, ad-penicillamine analogue, in patients with active rheumatoid arthritis

✍ Scribed by Naoya Sekiguchi; Hideto Kameda; Koichi Amano; Tsutomu Takeuchi


Publisher
Springer
Year
2006
Tongue
English
Weight
388 KB
Volume
16
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The efficacy and safety of leflunomide i
✍ J. R. Kalden; M. Schattenkirchner; H. SΓΆrensen; P. Emery; C. Deighton; B. Rozman πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 2 views

## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, open‐label extension of 2 phase III double‐blind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t

Pharmacokinetics of reduced d-penicillam
✍ Michael Butler; George Carruthers; Manfred Harth; David Freeman; John Percy; Dal πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 503 KB

Penicillamine (pp dimethylcysteine, 3 mercaptovaline) is a trifunctional amino acid with carboxyl, amino, and sufhydryl groups. The D-isomer is a remittive agent of similar efficacy to gold in the treatment of persistent rheumatoid arthritis (I). Despite the widespread use of the drug, little infor

Safety and efficacy of additional course
✍ Edward Keystone; Roy Fleischmann; Paul Emery; Daniel E. Furst; Ronald van Vollen πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 260 KB πŸ‘ 2 views

## Abstract ## Objective To determine the safety and efficacy of additional courses of rituximab in patients with rheumatoid arthritis (RA). ## Methods An open‐label extension analysis of RA patients previously treated with rituximab was conducted. Patients who had participated in any of 3 doubl